MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

Clinical trial NCT02673008 · COMPLETED

Trial details

NCT number: NCT02673008
Sponsor: Nanfang Hospital, Southern Medical University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Minimal Residual Disease Donor Lymphocyte Infusion Hematopoietic Stem Cell Transplantation Relapse

Start date: 2016-01-01
Primary completion: 2018-10-25
Enrollment: 206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.